BSE Live
Oct 10, 16:01Prev. Close
82.54
Open Price
83.54
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 10, 15:53Prev. Close
82.93
Open Price
82.93
Bid Price (Qty.)
83.10 (585)
Offer Price (Qty.)
0.00 (0)
Cash Flow of Bal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 5.73 | 12.11 | 8.55 | 12.06 | 9.80 | |
Net CashFlow From Operating Activities | 20.31 | 28.95 | 5.07 | 31.48 | 10.24 | |
Net Cash Used In Investing Activities | -14.90 | -18.43 | -22.08 | -13.43 | -6.66 | |
Net Cash Used From Financing Activities | -7.83 | -7.71 | 17.43 | -18.13 | -3.36 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | -2.42 | 2.81 | 0.42 | -0.08 | 0.21 | |
Cash And Cash Equivalents Begin of Year | 4.06 | 1.23 | 0.81 | 0.89 | 0.68 | |
Cash And Cash Equivalents End Of Year | 1.64 | 4.04 | 1.23 | 0.81 | 0.89 |
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
03.06.2025
Bal Pharma Consolidated March 2025 Net Sales at Rs 81.88 crore, down 13.47% Y-o-Y
04.03.2025
Bal Pharma Consolidated December 2024 Net Sales at Rs 73.15 crore, down 10.42% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
03.06.2025
Bal Pharma Consolidated March 2025 Net Sales at Rs 81.88 crore, down 13.47% Y-o-Y
04.03.2025
Bal Pharma Consolidated December 2024 Net Sales at Rs 73.15 crore, down 10.42% Y-o-Y